Skip to content

About us

eCounsel group

A boutique firm with unparalleled expertise in business and technology. We have good command of industrial ecology and legal practice, and have undertaken highly regarded cases. Because the small business scope, we pay more emphasis on effectiveness and efficiency, and choose clients with deliberation. The managing partner not only has extensive experiences in various legal issues more over than 20 years, but invests and manages several technology companies. In addition, he always checks each case rigorously. Clients’ business objectives are our primary focus. To achieve the same in the most cost-effective fashion trumps all seemingly sophisticated legal discussions.

Drug Prices in Taiwan Are Too Low

2016 - 10 - 28

In U.S, there usually is a co-payment charged at the pharmacies for most prescription drugs. Even for one or two generic drugs, you are paying tens of dollars.


美國人看醫生拿處方箋,到藥局領藥多半都有自負額 (co-payment),而且金額還不低;一次門診即便只是開給你普通的學名藥一兩種,進了藥局都得噴掉幾十鎂,萬一是仍在專利期內的原廠藥或罕病藥就更別提了。所以,真的有不少窮老美在看完醫生、確認完藥價後,就低頭抱病回家養病了;畢竟如果真的掏錢買藥,小孩就會沒飯吃、繳不起學費啊!

更讓他們憤怒的是,藥價居然還年年漲!一年平均漲11%(從2011起)!
Brand-name drug prices rose an average just over 11% a year from 2011 to 2015

本所之前的文章,批判台灣一手玩藥價調查(逼藥廠降價)、另一手讓病人拿藥幾近免費(門診藥費自負額上限NT$200),這是助長藥物濫取健保負擔沈重的元凶。

醫、藥,都是救人命的,搞不好也是會出人命的。對專業欠缺基本尊重,是台灣健保的問題;對病人冷血地予取予求,是美國制度的問題。

唉,過猶不及啊。

新聞來源:
What’s Happening With Drug Prices?

Recommended article 

Poverty and Education

According to the Taiwanese Ministry of Health and Welfare, data shows that in the first quarter of 2016, 2 out of 10 low-income/middle-income people are children under the age of 12. More troubling, underage teenagers account…

Thailand Embraces Blockchain Economy

While the two biggest economies in the world are still trying to figure out how to think about blockchain and crypto, a Southeast Asian country known for its booming tourism industry is gradually becoming an active…

Will a Free, Ad-Supported Model Work For Netflix?

The main ideas of the following article suggest Netflix to adopt a free, ad-supported tier into their model. We think it makes no sense at all. Continue reading